Dapagliflozin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4856 publications
Response by Myte et al to Letter Regarding Article, "Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin".
Journal: Circulation. Heart failure
Published: April 15, 2026
Letter by Wei et al Regarding Article, "Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin".
Journal: Circulation. Heart failure
Published: April 15, 2026
Exploring the anti-tumor potential of saxagliptin in A549 lung adenocarcinoma cells.
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
Published: April 09, 2026
Time-of-Day Differences in the Plasma N-Glycome of Normal and Obese Mice and the Effects of Dapagliflozin Administered in the Morning or at Night.
Journal: Journal of proteome research
Published: April 08, 2026
Reduction in Albuminuria with Dapagliflozin Exhibits Substantial Interindividual Variability: A Real-World Study Utilizing a Big Data Approach.
Journal: Balkan medical journal
Published: April 02, 2026
Corrigendum to 'Dapagliflozin activates the RAP1B/NRF2/GPX4 signaling and promotes mitochondrial biogenesis to alleviate vascular endothelial ferroptosis' [Cell Signal. 2025 Aug, 132:111824].
Journal: Cellular signalling
Published: March 28, 2026
Novel protein biomarkers for risk stratification and personalized medicine.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 24, 2026
Dapagliflozin and Crocin Ameliorate DOX-Induced Cardiotoxicity in Rats via Activating the Nrf-2/HO-1/NQO1 Pathway: A Comparative Study.
Journal: Immunopharmacology and immunotoxicology
Published: March 23, 2026
Correction: Sarman, E.; Asci, H. Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway. Int. J. Mol. Sci. 2026, 27, 2110.
Journal: International journal of molecular sciences
Published: March 18, 2026
Mechanism of Zuogui Jiangtang Yishen Prescription ameliorating diabetic kidney disease in db/db mice via regulation of Sema3a/VEGFA/VEGFR2 pathway
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: March 12, 2026
Letter to the Editor: Indication-Specific Cost-Effectiveness of Empagliflozin Versus Dapagliflozin: Implications for Clinical and Policy Decision-Making.
Journal: Hospital pharmacy
Published: March 12, 2026
Last Updated: 04/28/2026